- Indication
- Insomnia
- RAG rating
- Green
- Document type
- NICE technology appraisal
- Place
- Hertfordshire and West Essex ICB
- Output type
- Pharmacy / Prescribing
Daridorexant
Daridorexant
NICE
Technology Appraisal 922 recommends daridorexant as an option for
treating insomnia in adults with symptoms lasting for 3 nights or more per week
for at least 3 months, and whose daytime functioning is considerably affected,
only if:
- cognitive
behavioural therapy for insomnia (CBTi) has been tried but not worked, or
- CBTi
is not available or is unsuitable*.
Before considering daridorexant ensure:
- Any
circumstances/stressors associated with onset of insomnia have been
addressed
- Insomnia
related to other conditions such as sleep apnoea, restless legs have been
explored
- Information
has been provided to patients on insomnia and sleep hygiene - Prescribers
should refer to NICE Clinical
Knowledge Summary on insomnia for further information about the
assessment, diagnosis, and management of insomnia.
- Sleep
hygiene measures have been implemented and failed
- Patients
are asked to keep a sleep diary to help identify what is keeping them
awake. This is a useful tool which will help to pinpoint if there are any
patterns affecting sleep. This is best completed over a two-week period
and can be used as evidence of patient’s sleep-wake pattern which can help
with diagnosis. An example can be found here sleepdiary.pdf
(www.nhs.uk)
- Digital
CBTI has been tried
The length of treatment should be as short as possible.
Treatment with daridorexant should be assessed within 3 months of starting and
should be stopped in people whose long-term insomnia has not responded
adequately. If treatment is continued, assessment should be undertaken to
determine whether it is still working at regular intervals.
*Support for insomnia including Cognitive
Behavioural therapy for Insomnia – CBT-I
To access help for sleeping problems alongside
concerns about mental wellbeing, people
aged 16 or over who are registered with a GP in Hertfordshire and West Essex
can self-refer for support, including CBTi via NHS Talking Therapies.
People in Hertfordshire can self-refer and
access support including self-help guides and videos via: https://www.hpft-talkingtherapies.nhs.uk/. GPs and other
healthcare professionals can also refer someone to the service directly by
using the clinical referral form.
People in West Essex can self-refer and access
support via: https://www.vitahealthgroup.co.uk/nhs-services/nhs-mental-health/west-essex/ . GPs and other
healthcare professionals can also refer someone to the service directly by
using the referral link on this website.
The referral information will be reviewed, and service users will then be contacted to arrange an assessment to discuss their needs and identify the most appropriate support.
Locally developed resources are available on the website:
- Prescribing
support document for prescribers,
- Frequently
asked questions (FAQs)
document for patients on daridorexant,
- Frequently
asked questions (FAQs)
document for patients on long term insomnia